Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2022/08/31

Curated date: 2022/01/09

Curator: Joyessa

Revision editor(s): WikiWorks, Claregrieve1, Joyessa, Peace Sandy

Subjects

Location of subjects
Japan
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
HIV infection [X]Human immunodeficiency virus disease,[X]Human immunodeficiency virus disease (disorder),[X]Unspecified human immunodeficiency virus [HIV] disease,[X]Unspecified human immunodeficiency virus [HIV] disease (disorder),HIV - Human immunodeficiency virus infection,HIV INFECT,HIV Infection,HIV infection,HIV Infections,HIV infectious disease,HTLV III INFECT,HTLV III Infections,HTLV III LAV INFECT,HTLV III LAV Infections,HTLV WIII INFECTIONS,HTLV WIII LAV INFECTIONS,HTLV-III Infection,HTLV-III Infections,HTLV-III-LAV Infection,HTLV-III-LAV Infections,HUMAN IMMUNO VIRUS DIS,human immunodeficiency virus,Human immunodeficiency virus [HIV] disease,HUMAN IMMUNOdeficiency VIRUS [HIV] INFECTION,Human immunodeficiency virus caused disease or disorder,Human immunodeficiency virus disease,Human immunodeficiency virus disease (disorder),Human immunodeficiency virus disease or disorder,Human immunodeficiency virus infection,Human immunodeficiency virus infection (disorder),Human immunodeficiency virus infection, NOS,Human immunodeficiency virus infectious disease,human immunodeficiency virus infectious disease,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T,T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN,T Lymphotropic Virus Type III Infections, Human,T-Lymphotropic Virus Type III Infections, Human,Unspecified human immunodeficiency virus [HIV] disease (disorder),hIV infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
HIV Patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with HIV infection
Group 0 sample size Number of subjects in the control (unexposed) group
61
Group 1 sample size Number of subjects in the case (exposed) group
71

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3.0
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/08/31

Curated date: 2022/01/09

Curator: Joyessa

Revision editor(s): Joyessa, Claregrieve1

Source: Figure 2, Figure 3

Description: Differential microbial abundance between healthy controls and HIV-infected patients with CD4 counts > 500 cells/uL

Abundance in Group 1: increased abundance in HIV Patients

NCBI Quality ControlLinks
Actinomycetota
Oribacterium
Solobacterium
Lactobacillus
Lactobacillaceae
Merdimmobilis
Olsenella
Enterorhabdus
Mogibacterium
Aeromonadales
Parolsenella
Succinivibrionaceae
Succinivibrio
Megasphaera
Actinomycetaceae
Actinomycetales
Senegalimassilia
Slackia
Atopobiaceae
Holdemanella
Collinsella
Coriobacteriaceae
Erysipelotrichaceae
Acidaminococcaceae
Acidaminococcales
Catenibacterium
Eggerthellaceae
Prevotella
Erysipelotrichales
Prevotellaceae
Megamonas
Selenomonadaceae
Dialister
Bacilli
Coriobacteriia
Coriobacteriales
Veillonellaceae
Veillonellales
Selenomonadales
Negativicutes

Revision editor(s): Joyessa, Claregrieve1

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/08/31

Curated date: 2022/01/09

Curator: Joyessa

Revision editor(s): Joyessa, Claregrieve1

Source: Figure 3

Description: Differential microbial abundance between healthy controls and HIV-infected patients with CD4 counts > 500 cells/uL

Abundance in Group 1: decreased abundance in HIV Patients

NCBI Quality ControlLinks
Clostridia
Bacteroides
Bacteroidaceae
Enterobacteriaceae
Anaerostipes
Monoglobus
Alistipes
Fusicatenibacter
Rikenellaceae
Enterobacter
Carnobacteriaceae
Granulicatella
Pasteurellaceae
Haemophilus
Oscillospiraceae

Revision editor(s): Joyessa, Claregrieve1